STOCKSCOPE

Computershare (ASX: CPU): Shares Are Up Nearly 20%, But Can Earnings Keep Up?

Alison Elzayed

Alison Elzayed

Business & Finance Writer | StockScope

Published:15 Oct 2026
Computershare (ASX: CPU): Shares Are Up Nearly 20%, But Can Earnings Keep Up?

Computershare (ASX: CPU) shares have climbed approximately 19% in 2026, closing at $40.54 on October 14, yet the bigger question is whether earnings can sustain the momentum. We’re looking beyond the share-price rally at a business delivering higher profits, growing dividends and a new earnings target that investors will soon need to reassess.

The numbers look strong, but one detail matters

  • Share-price performance: Approximately 19% higher year to date.
  • FY26 revenue: US$3.2 billion, up 3.0%.
  • Management earnings per share: 145.2 US cents, up 7.3%.
  • Final dividend: A$0.65 per share, up 35.4% year on year.
  • FY27 earnings outlook: Management expects earnings per share to increase by approximately 6%.

Profits are growing faster than revenue

The distinction between revenue and earnings is central to Computershare’s investment story.

Its FY26 results showed management earnings growing faster than revenue, while earnings before interest and tax, excluding margin income, increased 8.3%. The margin on this business exceeded 18%, reflecting operating discipline and growth across its services.

Computershare also benefits from margin income earned on client balances. However, lower interest rates can pressure this revenue stream, making client cash balances, market activity and hedging arrangements important drivers of future performance.

The next test is harder than the last

Management expects another 6% increase in earnings per share in FY27. Delivering that growth would help support the share-price advance, but investors should distinguish between a credible earnings outlook and a guarantee of future returns.

The key uncertainty is whether operating growth can offset pressure from interest rates and other changes in margin income. A slowdown in earnings growth could challenge investor expectations, even if the underlying business remains profitable.

Investor Insight: Watch earnings quality, not just growth

We think the critical measure is growth in earnings excluding margin income. This helps investors assess whether Computershare’s core operations are strengthening independently of interest-rate movements. Sustained margin expansion would support the growth story, while weaker operating profitability could make the latest share-price gains harder to justify.

The next result could change the story

Computershare enters FY27 with stronger earnings, a higher dividend and a clear growth target. We’ll be watching whether its core operating margins continue to improve and whether margin income meets management’s expectations.

Can Computershare deliver its next earnings increase without relying too heavily on favourable cash-balance and interest-rate conditions? That is the question that could matter most for investors from here.

Alison Elzayed

Alison Elzayed

(Business & Finance Writer | StockScope)

Alison Elzayed is an experienced business and financial writer with more than 10 years of experience in the publishing industry, having previously worked as an author with Bloomsbury Publishing, specialising in business and finance. Throughout her career, Alison has developed a strong understanding of financial markets, corporate developments, economic trends and investment-related topics. Her background in financial publishing has equipped her with the ability to research complex subjects and communicate them in a clear, accurate and engaging manner.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...